Bicara Therapeutics Inc. (BCAX) — DEF 14A Filings
All DEF 14A filings from Bicara Therapeutics Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Bicara Therapeutics Files Annual Proxy Statement
— Apr 25, 2025 Risk: low
Bicara Therapeutics Inc. filed its definitive proxy statement on April 25, 2025, for its annual meeting on June 9, 2025. The company, located at 245 Main Street
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX